The largest holder of Medtronic stock is Vanguard Capital Management LLC, with 96.4 million shares (7.51% of the company), worth about $7.81 billion as of May 18, 2026. The 10 largest holders together own 41.3%.
In Q2 2026, 2,222 institutional holdings reports listed 1.27 billion shares worth $89.90 billion, up 15.5% in shares from Q1 2026.
Insiders reported 74 transactions in the last two years: 8 sales worth $11.62 million and 1 purchase. The newest one on file is from September 16, 2026 (Kiil Harry Skip, Officer).
Major holders as of May 18, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 16, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 96.4 million | 7.51% | $7.8B |
| BlackRock Advisors LLC | 84.1 million | 6.55% | $6.8B |
| Vanguard Capital Management LLC | 83.3 million | 6.49% | $6.7B |
| State Street Corporation | 61.7 million | 4.81% | $5.0B |
| JPMorgan Investment Management, Inc. | 51.0 million | 3.97% | $4.1B |
| Capital Research & Management Co. (Global Investors) | 41.9 million | 3.27% | $3.4B |
| Vanguard Portfolio Management LLC | 33.5 million | 2.60% | $2.7B |
| Geode Capital Management LLC | 28.7 million | 2.24% | $2.3B |
| Merrill Lynch International | 24.7 million | 1.92% | $2.0B |
| BlackRock Life Ltd. | 24.4 million | 1.90% | $2.0B |
As of May 18, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,222 | 1.27 billion | $89.9B |
| Q1 2026 | 2,330 | 1.10 billion | $95.7B |
| Q4 2025 | 2,411 | 1.10 billion | $105.0B |
| Q3 2025 | 2,285 | 1.13 billion | $107.0B |
| Q2 2025 | 2,246 | 1.10 billion | $95.8B |
| Q1 2025 | 2,275 | 1.08 billion | $98.5B |
| Q4 2024 | 2,223 | 1.07 billion | $85.4B |
| Q3 2024 | 2,169 | 1.09 billion | $97.6B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Kiil Harry Skip | Sep 16, 2026 | Officer | Sale at price 93.65 per share. | $138,883 |
| Blomquist Denise L | Sep 15, 2026 | Officer | Stock Gift at price 0.00 per share. | – |
| Thompson Kweli | Aug 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Martha Geoffrey S | Aug 3, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Quinn Michelle | Aug 3, 2026 | General Counsel | Stock Award(Grant) at price 0.00 per share. | – |
| Marinaro Michael | Aug 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Walter Matthew R. | Aug 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Pieton Thierry Jean Louis | Aug 3, 2026 | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Blomquist Denise L | Aug 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Kiil Harry Skip | Aug 3, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Walter Matthew R. | Jul 8, 2026 | Officer | Sale at price 83.15 per share. | $257,931 |
| Kiil Harry Skip | Jun 8, 2026 | Officer | Sale at price 80.44 - 80.45 per share. | $336,965 |
Newest 12 of 74 insider transactions in the last two years.
Vanguard Capital Management LLC, with 7.51% of the company (as of May 18, 2026). Next: BlackRock Advisors LLC (6.55%) and Vanguard Capital Management LLC (6.49%).
2,222 institutional holdings reports listed Medtronic shares in Q2 2026, 1.27 billion shares in all worth $89.90 billion.
In the last two years insiders reported 8 sales and 1 purchase (74 transactions in all); the newest on file is from September 16, 2026.